1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015

Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Hepatorenal Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatorenal Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hepatorenal Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Hepatorenal Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Unaccomplished Trials of Hepatorenal Syndrome 23
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Hepatorenal Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
La Jolla Pharmaceutical Company 30
Clinical Trial Overview of La Jolla Pharmaceutical Company 30
Ferring International Center S.A. 31
Clinical Trial Overview of Ferring International Center S.A. 31
Orphan Therapeutics, LLC 32
Clinical Trial Overview of Orphan Therapeutics, LLC 32
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Noorik Biopharmaceuticals AG 34
Clinical Trial Overview of Noorik Biopharmaceuticals AG 34
Max India Limited 35
Clinical Trial Overview of Max India Limited 35
Ikaria Holdings, Inc. 36
Clinical Trial Overview of Ikaria Holdings, Inc. 36
Curatis Pharma GmbH 37
Clinical Trial Overview of Curatis Pharma GmbH 37
Cumberland Pharmaceuticals, Inc. 38
Clinical Trial Overview of Cumberland Pharmaceuticals, Inc. 38
Clinical Trial Overview of Top Institutes / Government 39
Hospital Clinic de Barcelona 39
Clinical Trial Overview of Hospital Clinic de Barcelona 39
University of Virginia 40
Clinical Trial Overview of University of Virginia 40
All India Institute of Medical Sciences 41
Clinical Trial Overview of All India Institute of Medical Sciences 41
Austin Health 42
Clinical Trial Overview of Austin Health 42
Azienda Ospedaliera di Padova 43
Clinical Trial Overview of Azienda Ospedaliera di Padova 43
Charite - Universitatsmedizin Berlin 44
Clinical Trial Overview of Charite - Universitatsmedizin Berlin 44
Fundacio Clinic per a la Recerca Biomedica 45
Clinical Trial Overview of Fundacio Clinic per a la Recerca Biomedica 45
Isfahan University of Medical Sciences 46
Clinical Trial Overview of Isfahan University of Medical Sciences 46
Pomeranian Medical University 47
Clinical Trial Overview of Pomeranian Medical University 47
Postgraduate Institute of Medical Education and Research 48
Clinical Trial Overview of Postgraduate Institute of Medical Education and Research 48
Five Key Clinical Profiles 49
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Hepatorenal Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17
Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 19
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Hepatorenal Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015* 23
Hepatorenal Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by La Jolla Pharmaceutical Company, 2015* 30
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 31
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Orphan Therapeutics, LLC, 2015* 32
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Noorik Biopharmaceuticals AG, 2015* 34
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Max India Limited, 2015* 35
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ikaria Holdings, Inc., 2015* 36
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Curatis Pharma GmbH, 2015* 37
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015* 38
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2015* 39
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Virginia, 2015* 40
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015* 41
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 42
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera di Padova, 2015* 43
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2015* 44
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacio Clinic per a la Recerca Biomedica, 2015* 45
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2015* 46
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pomeranian Medical University, 2015* 47
Hepatorenal Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Postgraduate Institute of Medical Education and Research, 2015* 48

List of Figures
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Hepatorenal Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Hepatorenal Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Hepatorenal Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Hepatorenal Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Hepatorenal Syndrome to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17
Hepatorenal Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 18
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20
Hepatorenal Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25
Hepatorenal Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Hepatorenal Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 82

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.